Co-Authors
This is a "connection" page, showing publications co-authored by Temesgen Samuel and Deepa Bedi.
Connection Strength
2.169
-
Bedi D, Hassan M, Yirsaw A, Vikas B, Datta P, Samuel T. The immunopeptidome of colon cancer cells treated with topoisomerase inhibiting drug reveals differential as well as common endogenous protein sampling and display of MHC I-associated peptides. Mol Cell Oncol. 2025; 12(1):2471640.
Score: 0.932
-
Bedi D, Henderson HJ, Manne U, Samuel T. Camptothecin Induces PD-L1 and Immunomodulatory Cytokines in Colon Cancer Cells. Medicines (Basel). 2019 Apr 24; 6(2).
Score: 0.621
-
Gunturu DR, Hassan M, Bedi D, Datta P, Manne U, Samuel T. Unlocking the Potential of Therapy-Induced Cytokine Responses: Illuminating New Pathways in Cancer Precision Medicine. Curr Oncol. 2024 02 23; 31(3):1195-1206.
Score: 0.217
-
Hassan M, Trung V, Bedi D, Shaddox S, Gunturu D, Yates C, Datta P, Samuel T. Interference with pathways activated by topoisomerase inhibition alters the surface expression of PD-L1 and MHC I in colon cancer cells. Oncol Lett. 2023 Jan; 25(1):41.
Score: 0.200
-
King D, Khodary MG, Samuel T, Yates C, Bedi D. Obesity Influences the Expression of Key Immunomodulators in Normal Human Breast Tissue, Basal-like Breast Cancer Patients, and Cell Lines. Cancers (Basel). 2022 Nov 15; 14(22).
Score: 0.199